Teradyne, Inc. (TER) — Q2 2026 Earnings Preview

Company

Teradyne, Inc.

Ticker

NASDAQ: TER

Reporting Period

Q2 2026 (quarter ended June 30, 2026)

Earnings Date

July 28, 2026 (after market close); Conference Call July 29, 2026 at 8:30 a.m. ET

Prepared

July 28, 2026

Sector / Sub-sector

Semiconductors & Semiconductor Equipment / Automated Test Equipment (ATE)

1. Earnings Preview

Key Takeaway: The setup is mixed-to-cautious — consensus is a manageable bar after Q1's record beat, but the stock has already de-rated sharply since earnings and the key swing factor is whether Q2 SoC/compute revenue and gross margin can clear the low end of guidance, with any signal on H2 VIP compute timing the single biggest catalyst in either direction.

Heading into Q2 2026 results, Teradyne faces a bar that is achievable but not low: consensus revenue of ~$1.22B sits near the midpoint of the $1.15B–$1.25B guidance range issued April 29, and non-GAAP EPS consensus of ~$2.05 is just below the $1.86–$2.15 guidance midpoint of ~$2.01, leaving modest room for a beat but little cushion if execution slips. Management's posture on the Q1 call was directionally confident on first-half demand — AI-driven revenue reached ~70% of Q1 sales, merchant GPU first multi-system production orders were received, and memory test demand was described as "even stronger than our view in January" — but the tone was deliberately cautious on H2, with management widening the full-year first-half weighting range to 55%–60% (from a prior 60% point estimate) and explicitly flagging "quite limited" H2 visibility for merchant GPU. Estimate revisions have been broadly stable since the Q1 print — Q2 consensus revenue is essentially flat vs. the post-Q1 baseline (~$1.215B vs. ~$1.212B), suggesting the Street has largely digested guidance without adding incremental optimism or pessimism. The stock, however, has told a different story: TER peaked near $484 on June 30 before a sharp ~31% drawdown to ~$335 by late July, driven by multiple compression (NTM P/E contracted from ~50x to ~39x over three months) rather than estimate cuts, leaving the stock pricing in meaningful execution risk ahead of the print. The wildcard is H2 VIP compute timing — management has flagged that the next-generation VIP wave is expected in early 2027 but could "bleed into" late 2026, and any pull-forward signal on the call would be a material positive catalyst; conversely, any further widening of the H2 uncertainty range would likely extend the de-rating.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus sits near the midpoint of guidance on revenue (~$1.22B vs. $1.20B midpoint) and just below the EPS midpoint (~$2.05 vs. ~$2.01), making this a manageable but not easy bar; SoC Test revenue and gross margin are the bigger swing factors given the peak-volume and mix-driven dynamics flagged by management.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual (Prior Year)

Q2 2026 Consensus Estimate

YoY Change

Q2 2026 Guidance

Consensus vs. Guidance Midpoint

Net Revenue ($M)

$1,282.5

$651.8

$1,215.6

+86.5%

$1,150–$1,250 ($1,200M mid)

+1.3%

Non-GAAP EPS (Diluted)

$2.56

$0.57

$2.05

+259.6%

$1.86–$2.15 ($2.005M mid)

+2.2%

Semiconductor Test Revenue ($M)

$1,111.0

$491.9

$1,042.0

+111.8%

No segment-level guidance provided

N/A

SoC Test Revenue ($M)

$881.5

$396.6

$813.0

+105.0%

No segment-level guidance provided

N/A

Memory Test Revenue ($M)

$203.0

$60.9

$187.3

+207.5%

No segment-level guidance provided

N/A

Robotics Revenue ($M)

$91.0

$74.9

$87.7

+17.1%

No segment-level guidance provided

N/A

Gross Profit – Non-GAAP ($M)

$781.0

$373.3

$713.3

+91.1%

58%–59% gross margin (normalized)

~58.7% implied vs. 58–59% range

Sources: Visible Alpha Consensus and Actuals Data (Net revenues, EPS – Diluted – Operating, Semiconductor Test, SoC Test, Memory Test, Robotics, Gross profit/(loss) – Operating). Guidance from Q1 2026 Earnings Call (April 29, 2026).

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

KPI 1: Net Revenue ($M) | KPI 2: Non-GAAP EPS (Diluted)

Quarter

Revenue Reported ($M)

Revenue Consensus ($M)

Revenue Surprise %

EPS Reported

EPS Consensus

EPS Surprise %

Result

Q1 2026

$1,282.5

$1,214.7

+5.6%

$2.56

$2.11

+21.3%

Beat / Beat

Q4 2025

$1,083.3

$975.6

+11.1%

$1.80

$1.37

+31.4%

Beat / Beat

Q3 2025

$769.2

$744.9

+3.3%

$0.85

$0.79

+7.6%

Beat / Beat

Q2 2025

$651.8

$650.5

+0.2%

$0.57

$0.54

+5.6%

Beat / Beat

Q1 2025

$685.7

$683.9

+0.3%

$0.75

$0.62

+21.0%

Beat / Beat

Q4 2024

$752.9

$742.1

+1.5%

$0.95

$0.92

+3.3%

Beat / Beat

Q3 2024

$737.3

$717.2

+2.8%

$0.90

$0.79

+13.9%

Beat / Beat

Q2 2024

$752.9

N/A — not in VA

N/A

$0.86

N/A — not in VA

N/A

N/A

Pattern: Teradyne has beaten consensus on both revenue and non-GAAP EPS in every quarter with available data over the past seven quarters, with the magnitude of beats accelerating sharply in Q4 2025 and Q1 2026 as AI-driven demand surged well above Street expectations — the consistent beat track record sets a high implicit bar for Q2 2026.

Source: Visible Alpha Consensus and Actuals Data (Net revenues, EPS – Diluted – Operating).

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates for Q2 2026 and FY 2026 have been remarkably stable since the Q1 print — revenue and EPS revisions are essentially flat — indicating the Street has fully absorbed guidance without adding incremental optimism; the lack of upward revision despite strong peer read-throughs suggests the bar is not being raised, which is a mild positive setup.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (as of May 6, 2026)

Current Consensus (Jul 28, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Earnings Call, Apr 29)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Net Revenue — Q2 2026 ($M)

$1,212.4

$1,215.6

+0.3%

$1,150–$1,250M ($1,200M mid)

Unchanged

+1.3% above midpoint

Non-GAAP EPS — Q2 2026

$2.052

$2.050

-0.1%

$1.86–$2.15 ($2.005 mid)

Unchanged

+2.2% above midpoint

Net Revenue — FY 2026 ($M)

$4,494.1

$4,513.3

+0.4%

55%–60% of annual revenue in H1 (implies ~$4.3B–$4.7B FY range)

Unchanged

Within implied range

Non-GAAP EPS — FY 2026

$7.221

$7.389

+2.3%

No explicit FY EPS guidance provided

N/A

N/A

SoC Test Revenue — Q2 2026 ($M)

$814.8

$813.0

-0.2%

No segment guidance

N/A

N/A

Memory Test Revenue — Q2 2026 ($M)

$186.6

$187.3

+0.4%

No segment guidance; back-half weighted per mgmt

N/A

N/A

Source: Visible Alpha Consensus and Actuals Data. As-of-date baseline uses May 6, 2026 (approximately 5 trading days post Q1 2026 earnings on April 29, 2026).

The near-zero revision delta across all KPIs since the Q1 print is notable: the Street has not added incremental optimism despite strong peer commentary (AMKR, TXN, AEHR all signaling robust AI/compute demand) and has not cut estimates despite the stock's ~31% drawdown from its June 30 peak. This divergence between price action and stable estimates suggests the de-rating has been multiple-driven rather than fundamental, and that the bar entering Q2 results is essentially unchanged from where it was set on April 29.

5. Stock Performance

Key Takeaway: TER's ~12% gain since Q1 earnings (Apr 28 close: $380) masks extreme volatility — the stock rallied to $484 (+27%) by June 30 before a sharp ~31% reversal to ~$335 by late July; the drawdown has been entirely multiple-driven (NTM P/E compressed from ~50x to ~39x) with estimates essentially unchanged, suggesting sentiment and macro/sector rotation are the dominant forces rather than fundamental deterioration.

Chart: TER vs. SOXX vs. S&P 500 — Indexed to 100 at April 28, 2026 (Last Q1 Earnings Date)

Note: The chart below indexes all three series to 100 at the April 28, 2026 close (the day before Q1 2026 earnings were reported after market close). TER is shown in dark navy, SOXX (PHLX Semiconductor ETF) in mid-grey dashed, and S&P 500 (SPY) in light grey dashed. Key events are annotated.

Date

TER Price

TER Indexed

SOXX Indexed

SPY Indexed

Event

Apr 28, 2026

$380.13

100.0

100.0

100.0

Q1 2026 Earnings (base)

Apr 29, 2026

$306.33

80.6

102.6

100.0

Q1 results released; stock -19.4% on mixed Q2 guidance

May 6, 2026

$382.48

100.6

115.5

103.1

Recovery; US-China trade truce announced

Jun 2, 2026

$392.62

103.3

138.0

106.7

BofA Technology Conference

Jun 15, 2026

$432.41

113.8

143.3

106.1

Sector rally; AI capex headlines

Jun 30, 2026

$483.84

127.3

146.1

104.9

TER peak; Q2 end

Jul 7, 2026

$343.11

90.3

125.8

105.1

Sharp sector rotation; TER -29% from peak in 5 days

Jul 28, 2026

$334.77

88.1

117.7

103.9

Q2 2026 Earnings Day (today)

Source: Stock Price Data (Yahoo Finance). Sector ETF: SOXX (iShares Semiconductor ETF), selected as the most appropriate sub-sector benchmark for ATE/semiconductor capital equipment.

Performance Summary (Apr 28 → Jul 28, 2026): TER: -11.9% | SOXX: +17.7% | SPY: +3.9%. TER has dramatically underperformed both the semiconductor sector and the broader market since Q1 earnings, despite stable estimates. The stock's peak-to-trough move of -31% (Jun 30 → Jul 7) was driven by sector rotation and multiple compression, not fundamental revision. NTM EV/EBITDA compressed from ~37.8x (1 month ago) to ~29.2x currently, and NTM P/E from ~50x to ~39x over three months. The stock is now pricing in meaningful execution risk and/or H2 demand disappointment, creating an asymmetric setup if Q2 results and Q3 guidance are in-line or better.

6. Peer Commentaries & Current-Quarter Read-Through

Key Takeaway: Peer commentary from the last 60 days is broadly positive for TER's Q2 2026 print and forward outlook — AMKR's record Q2 computing revenue and accelerating Q3 compute ramp, TXN's above-seasonal Q3 guidance and strong industrial/auto demand, and AEHR's record backlog and AI processor burn-in acceleration all point to robust ATE demand; the only consistent negative read-through is ongoing mobile/communications softness, which is a known and manageable headwind for TER.

Inclusion Logic: Only commentary from the last 60 days (on or after May 28, 2026) that addresses current-quarter (Q2 2026 calendar) conditions, forward demand, or the outlook for TER's end markets is included. Peer earnings calls discussing prior-quarter results are included only where management explicitly commented on current-quarter trends or forward guidance. AMKR Q2 2026 earnings (July 27, 2026) and AEHR Q4 FY2026 earnings (July 14, 2026) are included because they reported Q2 2026 calendar results and provided Q3 2026 forward guidance. TXN Q2 2026 earnings (July 22, 2026) is included for the same reason. The BofA Technology Conference (June 2, 2026) is TER's own management commentary and is covered in Section 3. No prior-quarter-only commentary is included.

Amkor Technology (AMKR) — Q2 2026 Earnings Call (July 27, 2026)

Read-Through: Strongly Positive

Texas Instruments (TXN) — Q2 2026 Earnings Call (July 22, 2026)

Read-Through: Positive

Aehr Test Systems (AEHR) — Q4 FY2026 Earnings Call (July 14, 2026)

Read-Through: Positive

7. Material News & Developments

Key Takeaway: The most important post-Q1 development is the confirmation that merchant GPU first multi-system production orders shipped and entered production in Q2 — a milestone that validates TER's fast-follower strategy and sets up a multi-year GPU share ramp; the two April acquisitions (MultiLane, TestInsight) add strategic optionality in high-speed I/O and test software.

8. Insider Transaction Activity

Key Takeaway: All insider transactions since Q1 earnings are 10b5-1 planned sales — no discretionary open-market selling and zero open-market buying; the mechanical, pre-scheduled nature of all activity means there is no directional signal from insiders heading into Q2 results.

Name

Title

Transaction Type

Shares

Date

Note

Smith, Gregory Stephen

President & CEO, Director

10b5-1 Planned Sale

4,000

Jul 15, 2026

Pre-scheduled 10b5-1 plan; routine monthly cadence; no discretionary signal.

Matz, Marilyn

Director

10b5-1 Planned Sale

1,200

Jul 15, 2026

Pre-scheduled 10b5-1 plan; consistent with prior months.

Johnson, Mercedes

Director

10b5-1 Planned Sale

167

Jul 1, 2026

Pre-scheduled 10b5-1 plan; consistent with prior months.

Smith, Gregory Stephen

President & CEO, Director

10b5-1 Planned Sale

4,000

Jun 15, 2026

Pre-scheduled 10b5-1 plan; routine monthly cadence.

Matz, Marilyn

Director

10b5-1 Planned Sale

1,200

Jun 15, 2026

Pre-scheduled 10b5-1 plan.

Johnson, Mercedes

Director

10b5-1 Planned Sale

167

Jun 2, 2026

Pre-scheduled 10b5-1 plan.

Matz, Marilyn

Director

10b5-1 Planned Sale

400

May 21, 2026

Pre-scheduled 10b5-1 plan.

Matz, Marilyn

Director

10b5-1 Planned Sale

800

May 15, 2026

Pre-scheduled 10b5-1 plan.

Driscoll, Ryan

VP, General Counsel & Secretary

10b5-1 Planned Sale

680

May 7, 2026

Pre-scheduled 10b5-1 plan.

Source: SEC Form 4 Filings Database (Insider Transaction Data). All transactions are Form 4 open-market dispositions (code S) executed under pre-established 10b5-1 trading plans. No open-market purchases were filed in the period. The CEO's monthly 4,000-share sales and Director Matz's recurring monthly sales are consistent with a long-running, pre-scheduled plan and carry no directional information about management's view of Q2 results.

9. Risks & Considerations

Key Takeaway: The primary risk is H2 demand visibility — if management widens the uncertainty range further or signals VIP compute demand is more back-half weighted than expected, the stock's already-compressed multiple could face additional pressure; the primary upside catalyst is any pull-forward signal on the next-generation VIP compute wave or merchant GPU ramp acceleration.

Downside Risks

Upside Catalysts

Appendix: Valuation Context

Metric

Current (Jul 27, 2026)

1 Month Ago

3 Months Ago

6 Months Ago

12 Months Ago

NTM EV/EBITDA

29.2x

37.8x

42.8x

31.1x

16.6x

NTM P/E

39.3x

50.3x

57.0x

42.5x

23.5x

NTM EV/Sales

10.7x

13.5x

13.9x

9.2x

4.5x

NTM P/FCF

47.0x

58.9x

64.7x

46.1x

28.0x

Stock Price

$334.81

~$483 (peak)

~$374

~$229

~$91

Source: Stock Performance Decomposition Data. NTM multiples as of July 27, 2026. Historical multiples derived from price performance and valuation decomposition analysis.

Note on 12-month performance: TER is up +267% over the trailing 12 months, driven by a combination of ~76% multiple expansion (NTM EV/EBITDA from 16.6x to 29.2x) and strong earnings growth. The 3-month and 1-month periods show the reversal: the stock is down ~20% and ~29% respectively, driven almost entirely by multiple compression with estimates essentially unchanged. This decomposition confirms the de-rating is sentiment/macro-driven, not fundamental.